Industry reports
Editor highlights

Publication dates

All regions

Bladder Cancer Research Reports, April 2014

You might be interested in: cancer, medical equipment, therapeutics, more »


 

1-20 of about 8 500 reports for Bladder Cancer
Bladder Cancer Drug Pipeline Update 2014

Bladder Cancer Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • March 2014
  • by Bioseeker

... bladder cancer drug pipeline update 2014 according to the american cancer society, bladder cancer is the 6th most common cancer in the u.S. bladder cancer occurs among both men and women. When found ...

Bladder Cancer Drug Pathway Analyzer 2014

Bladder Cancer Drug Pathway Analyzer 2014

  • $ 1 499
  • Industry report
  • March 2014
  • by Bioseeker

... Specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any bladder cancer drug-pathway relationship by using up to four ...

Bladder Cancer Partnering 2009-2014

Bladder Cancer Partnering 2009-2014

  • $ 995
  • Industry report
  • March 2014
  • by Currentpartnering

... Report contains over 25 links to online copies of actual bladder cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available ...

Drug and Medication in United States: Bladder Cancer – Pipeline Review, H1 2012

Drug and Medication in United States: Bladder Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... Of bladder cancer therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and grow business potential ...

World Drug and Medication: Malignant Mesothelioma – Pipeline Review, H1 2012

World Drug and Medication: Malignant Mesothelioma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... In bladder cancer and mesothelioma models at aacr annual meeting 2013 92feb 14, 2013: verastem files for orphan disease status for vs-6063 in mesothelioma 93jan 09, 2013: verastem enters biomarker ...

Bladder Cancer Global Clinical Trials Review, H1, 2014

Bladder Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • February 2014
  • by Global Data

... Clinical trials review, h1, 2014" provides data on the bladder cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on bladder cancer ...

Metabolon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Metabolon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Biomarkers for various diseases such as prostate cancer, kidney cancer, bladder cancer, nephrotoxicity of chemotherapy drugs and diabetes/insulin resistance. The company offers services for scientists ...

H. Lee Moffitt Cancer Center & Research Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

H. Lee Moffitt Cancer Center & Research Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Chemotherapy, radiation, integrative medicine, pain management, well-being, emotional support, spiritual support and other patient services. Moffitt provides treatment for anal cancer, bladder cancer, breast ...

PrognosDx Health, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

PrognosDx Health, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... For the treatment of cancer and other complex diseases. Its products include prognoscore, and rxscore. Prognosdx's prognoscore is used in the treatment of prostate cancer and bladder cancer. The company's rx ...

Bostwick Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bostwick Laboratories, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... And biotechnology industries. The company partner's with american cancer society, bladder cancer genitourinary, diversified conference management, inc., The krongrad institute, prostate cancer research institute ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.